Giant cell tumor of a rib following denosumab treatment

Giant cell tumor (GCT) of the bone is an aggressive lytic lesion, commonly treated with surgery. Denosumab is a relatively recently introduced osteoclast activation inhibitor used for neoadjuvant therapy of GCT. Here we report the case of a GCT of a rib undergoing extensive osteosclerosis on compute...

Full description

Bibliographic Details
Main Authors: Alexandre Semionov, John Kosiuk
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:Radiology Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043318301201
_version_ 1818197631869911040
author Alexandre Semionov
John Kosiuk
author_facet Alexandre Semionov
John Kosiuk
author_sort Alexandre Semionov
collection DOAJ
description Giant cell tumor (GCT) of the bone is an aggressive lytic lesion, commonly treated with surgery. Denosumab is a relatively recently introduced osteoclast activation inhibitor used for neoadjuvant therapy of GCT. Here we report the case of a GCT of a rib undergoing extensive osteosclerosis on computed tomography imaging following treatment with denosumab. Keywords: Giant cell tumor, Denosumab, Osteosclerosis
first_indexed 2024-12-12T01:53:03Z
format Article
id doaj.art-046ce7ec7d394695bd328c901aad0610
institution Directory Open Access Journal
issn 1930-0433
language English
last_indexed 2024-12-12T01:53:03Z
publishDate 2018-10-01
publisher Elsevier
record_format Article
series Radiology Case Reports
spelling doaj.art-046ce7ec7d394695bd328c901aad06102022-12-22T00:42:26ZengElsevierRadiology Case Reports1930-04332018-10-0113510181020Giant cell tumor of a rib following denosumab treatmentAlexandre Semionov0John Kosiuk1Corresponding author.; McGill University Health Centre, Department of Diagnostic Radiology, Montreal General Hospital, 1650 Cedar Avenue, Montreal, QC H3G 1A4, CanadaMcGill University Health Centre, Department of Diagnostic Radiology, Montreal General Hospital, 1650 Cedar Avenue, Montreal, QC H3G 1A4, CanadaGiant cell tumor (GCT) of the bone is an aggressive lytic lesion, commonly treated with surgery. Denosumab is a relatively recently introduced osteoclast activation inhibitor used for neoadjuvant therapy of GCT. Here we report the case of a GCT of a rib undergoing extensive osteosclerosis on computed tomography imaging following treatment with denosumab. Keywords: Giant cell tumor, Denosumab, Osteosclerosishttp://www.sciencedirect.com/science/article/pii/S1930043318301201
spellingShingle Alexandre Semionov
John Kosiuk
Giant cell tumor of a rib following denosumab treatment
Radiology Case Reports
title Giant cell tumor of a rib following denosumab treatment
title_full Giant cell tumor of a rib following denosumab treatment
title_fullStr Giant cell tumor of a rib following denosumab treatment
title_full_unstemmed Giant cell tumor of a rib following denosumab treatment
title_short Giant cell tumor of a rib following denosumab treatment
title_sort giant cell tumor of a rib following denosumab treatment
url http://www.sciencedirect.com/science/article/pii/S1930043318301201
work_keys_str_mv AT alexandresemionov giantcelltumorofaribfollowingdenosumabtreatment
AT johnkosiuk giantcelltumorofaribfollowingdenosumabtreatment